A model informed approach to assess the risk of checkpoint inhibitors induced myocarditis (Frontiers in Pharmacology, 2022)

(untitled) - ven der Vegt, S; Wang, Y; Polonchuk, L; Wang, K; Waters, S; Baker, RE